Send Enquiry
CURE
Tablets
Packaging and packing Type
Alu Alu | 10x10
MRP :
₹137
PTR :
₹97.86
PTS :
₹88.07
An anti-diabetic drug that reduces glycemia in patients with type 2 diabetes mellitus. (B Ahrén, 2011) Enhances pancreatic islet cell responsiveness... Read More
Composition
Send Enquiry
India’s Largest Pharma Franchise
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
An anti-diabetic drug that reduces glycemia in patients with type 2 diabetes mellitus. (B Ahrén, 2011) Enhances pancreatic islet cell responsiveness to glucose. (Degrande, 2008) Improves the impaired sensitivity of the beta cells to glucose. (Foley, 2019) A well-tolerated and efficacious medicine in improving glycemic control in patients with type 2 diabetes mellitus. (Degrande, 2008) An effective therapy for glycemic control with a low risk of hypoglycemia. (L Cai, 2012) A safe and effective therapeutic option for patients with type 2 diabetes mellitus, both as monotherapy and as an add-on treatment. (Eleni Bekiari, 2016) A safe option for managing patients with type 2 diabetes mellitus. (Chantal Mathieu, 2017) An efficacious candidate in reducing glycosylated hemoglobin, fasting plasma glucose, and postprandial glucose levels. (Prato, 2007) An important choice for use in combination with metformin, a sulfonylurea, or a thiazolidinedione in patients with type 2 diabetes who require combination therapy. (Keating, 2010) An attractive therapeutic option in patients where metformin monotherapy alone is not sufficient. (Thomas Forst, 2014) More effective in decreasing HbA1c and enables patients to reach glycemic control than sitagliptin, and linagliptin. (Yun-Zhao Tang, 2015)
Headache, Common cold, Cough, Constipation, Dizziness
Type 2 diabetes mellitus
Temp data
Storage Condition
Product details for storage condition Product details for storage condition Product details for storage condition Product details for storage condition
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner